Voprosy meditsinskoi khimii (ISSN 0042-8809)

Platinum derivative effect on activity of microsomal NADPH-oxidoreductases


1. Institute of Oncology, Tomsk Research Center, Siberian Branch of Russian Academy of Medical Sciences
2. Health Research Foundation, Kyoto
PubMed Id: 11693025
Year: 2001 vol: 47  issue:4  pages: 373-381
Abstract: The influence of platinum derivatives, cisplatin (cis-diamminedichloroplatinum) and imidazolplatin (cis-diimidazoledichloroplatinum) on the activity of rat liver microsomal NADPH-oxidoreductases was investigated in vitro using spectrophotometrical and chemiluminometrical methods. In the range of concentrations from 1 to 12 µM cisplatin inhibited NADPH-cytochrome c-reductase activity and NADPH/lucigenin-dependent chemiluminescence of microsomes. The 3 µM cisplatin decreased the NADPH-dependent reductase activity by 50%. At concentrations less than 2,5 mM sanazole (drug AK-2123) did not prevent the inhibiting influence of cisplatin on microsomal NADPH-dependent reductases. Imidazolplatin insignificantly inhibited NADPH-reductases. It is concluded that negligible inhibiting effect of imidazolplatin on microsomal NADPH-oxidoreductase allows us to consider this platinum derivative as a promising compound for further experimental trials as anticancer drug with low toxic action on the normal tissues of an organism.
Download PDF:
Reference: Shchepetkin I.A., Plotnikov V.M., Kagiya V.T., Platinum derivative effect on activity of microsomal NADPH-oxidoreductases, Voprosy meditsinskoi khimii, 2001, vol: 47(4), 373-381.